Skylegs Aviation Management Platform Elevates ID Verification Accuracy with Regula
Skylegs, an aviation management platform used by 90 aircraft operators in 25 countries, has chosen Regula Document Reader SDK to enable automated data reading and... Read more.
Alipay Enhances Accessible Payment Service in Support of Asian Para Games
HANGZHOU, China–(BUSINESS WIRE)–As part of Ant Group’s “Asian Para Games Support Initiative,” Alipay, the leading digital payment and lifestyle... Read more.
CoStar Group Offers to Acquire Leading UK Residential Property Portal OnTheMarket
Backed by Costar Group’s fortress balance sheet, the acquisition seeks to create number one UK property portal by combining the strengths of leading commercial... Read more.
Turkish Invoice Financing Platform Figopara Turns to Provenir’s Risk Decisioning Capabilities to Fuel its International Growth
Provenir’s flexible platform will enable Figopara to better evaluate credit risk and quickly expand into new jurisdictions whilst remaining compliant with local... Read more.
GeNeuro and Verily Collaborate to Advance Long-COVID Research
Partnership to combine GeNeuro’s expertise in HERVs with Verily’s Immune Profiler and Workbench platforms to investigate biomarkers related to HERV-W GENEVA,... Read more.
Corriere della Sera Innovates News Reading with Bespoke Branded Voices from ReadSpeaker
ReadSpeaker’s industry-leading voice expertise leveraged by leading Italian newspaper to enhance the reader experience MILAN–(BUSINESS WIRE)–ReadSpeaker,... Read more.
TRADING UPDATE – October 2023
AMSTERDAM–(BUSINESS WIRE)–Regulatory News: 7.00am BST 19 October 2023 TRADING UPDATE – October 2023 RELX, the global provider of information-based... Read more.
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
Joint development collaboration to bring leading-edge nanopore sequencing into clinical laboratories at Mayo Clinic to increase understanding and improve treatment... Read more.
Numab Therapeutics Announces First Patient Dosed in Phase 1 Multiple Ascending Dose (MAD) Study of NM26 for Moderate to Severe Atopic Dermatitis
NM26 is a first-in-class bi-specific antibody designed to simultaneously block multiple targets, targeting the underlying inflammation as well as the neuroinflammatory... Read more.
Innate Pharma 2024 Financial Calendar
MARSEILLE, France–(BUSINESS WIRE)–#immunotherapy–Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today... Read more.